Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 318Colonic Neoplasms 90Rectal Neoplasms 82Neoplasm Metastasis 42Pancreatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 35Esophageal Neoplasms 25Neoplasms 21Stomach Neoplasms 20Esophageal Squamous Cell Carcinoma 14Adenocarcinoma Of Esophagus 12Squamous Cell Carcinoma of Head and Neck 11Lung Neoplasms 11Head and Neck Neoplasms 11Colorectal Cancer Metastatic 11Breast Neoplasms 9Gastrointestinal Neoplasms 7Ovarian Neoplasms 6Anus Neoplasms 6Hereditary Sensory and Autonomic Neuropathies 5Endometrial Neoplasms 5Cholangiocarcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Salivary Gland Neoplasms 4Recurrence 4Digestive System Neoplasms 4Advanced Colorectal Cancer 4Tongue Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 7Radiotherapy 6Radiosurgery 4pembrolizumab 3Specimen Handling 3Paclitaxel 3Fluorodeoxyglucose F18 3Carboplatin 3sargramostim 2cediranib 2Thiotepa 2Radiation 2Nivolumab 2Melphalan 2IFL protocol 2Granulocyte Colony-Stimulating Factor 2Genetic Testing 2Gemcitabine 2FAPI-46 2Busulfan 2130-nm albumin-bound paclitaxel 2tipifarnib 1sodium thiosulfate 1regorafenib 1paclitaxel-Angiopep-2 conjugate 1montelukast 1etoposide phosphate 1entrectinib 1entinostat 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Cetuximab × Gastrointestinal × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡